1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 285 F.Supp.3d
  5. 285 F.Supp.3d 776 (2018)
 

HOSPIRA, INC. v. AMNEAL PHARMACEUTICALS, LLC

Civil Action No. 15-cv-697-RGA.

285 F.Supp.3d 776 (2018)

HOSPIRA, INC., Plaintiff; v. AMNEAL PHARMACEUTICALS, LLC, Defendant.

United States District Court, D. Delaware.

Filed January 22, 2018.

Editors Note
Applicable Law: 35 U.S.C. § 145
Cause: 35 U.S.C. § 145 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER

Attorney(s) appearing for the Case

Arthur G. Connolly, III and Ryan P. Newell , CONNOLLY GALLAGHER LLP, Wilmington, DE; Bradford P. Lyerla , Sara T. Horton , and Yusuf Esat , JENNER & BLOCK LLP, Chicago, IL., Attorneys for Plaintiffs.

Frederick L. Cottrell, III , Kelly E. Farnan , and Christine D. Haynes , RICHARDS, LAYTON & FINGER, P.A., Wilmington, DE; Steven A. Maddox , Jeremy J. Edwards , Matthew C. Ruedy , and Kaveh V. Saba , MADDOX EDWARDS PLLC, Washington, D.C., Attorneys for Defendant.

MEMORANDUM OPINION

Plaintiff brought this patent infringement action against Amneal Pharmaceuticals, LLC in 2015. (D.I. 1). At issue in this case are ready-to-use formulations of the compound dexmedetomidine. Dexmedetomidine itself is claimed in U.S. Patent No. 4,910,214 ("the '214 patent"), which is not at...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases